VRAYLAR is a brand that offers treatment options for adults with Bipolar I Depression or Major Depressive Disorder. It can be used as an add-on medication, alongside antidepressants, to treat Major Depressive Disorder. Additionally, it can be used to treat acute manic or mixed episodes and depressive episodes in adults with Bipolar I disorder. However, it is important to note that VRAYLAR is not approved for treating patients with dementia-related psychosis.

It is crucial to be aware of the safety information associated with VRAYLAR. Elderly people with dementia-related psychosis who take VRAYLAR are at an increased risk of death. The medication can also increase suicidal thoughts or actions, especially in children and young adults. Other potential side effects of VRAYLAR include stroke, neuroleptic malignant syndrome, uncontrolled body movements, late-occurring side effects, problems with metabolism, decreased blood pressure, falls, seizures, sleepiness, increased body temperature, and difficulty swallowing.

Before taking VRAYLAR, it is important to consult with a healthcare provider and disclose any medical conditions, medications, or allergies. Pregnant or breastfeeding individuals should also seek medical advice. Overall, VRAYLAR provides treatment options for individuals experiencing specific mental health conditions, but it is essential to consider the potential risks and side effects associated with the medication.